Aldolase B inhibits metastasis through Ten–Eleven Translocation 1 and serves as a prognostic biomarker in hepatocellular carcinoma

BACKGROUND: Downregulation of Aldolase B (ALDOB) has been reported in hepatocellular carcinoma. However, its clinical significance and its role in pathogenesis of HCC remain largely unknown. METHODS: We analyzed the expression of ALDOB and its clinical features in a large cohort of 313 HCC patients...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Cancer
Main Authors: Tao, Qi-fei, Yuan, Sheng-xian, Yang, Fu, Yang, Sen, Yang, Yuan, Yuan, Ji-hang, Wang, Zhen-guang, Xu, Qing-guo, Lin, Kong-ying, Cai, Jie, Yu, Jian, Huang, Wei-long, Teng, Xiao-lei, Zhou, Chuan-chuan, Wang, Fang, Sun, Shu-han, Zhou, Wei-ping
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2015
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4574028/
https://ncbi.nlm.nih.gov/pubmed/26376879
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12943-015-0437-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados